The third series of White Papers on myopia, prepared by the International Myopia Institute (IMI) will be released in a special issue of the peer reviewed journal Investigative Ophthalmology and Visual Science (IOVS).
Acknowledging the “growing number of myopia management options available”, Dr Nina Tahhan, Program Director of the IMI, and Director of Clinical Research at Brien Holden Vision Institute, said the White Papers “provide consensus and summarise the latest evidence” in an accessible format ready for practising clinicians to implement in practice.
The first two series of IMI White Papers, released in 2019 and 2021 respectively, provided consensus and clinical management guidance for myopia development and management.
The third series highlights evidence around onset, progression, and management of myopia in less typical young adult and paediatric populations, the role of the choroid in eye growth control and myopia management, and a detailed anatomical paper on non-pathological ocular tissue changes observed in moderate to high myopia.
Additionally, the series includes a report on the results of an international survey of practitioners on myopia management attitudes and strategies in clinical practice, and a digest which updates the latest evidence from topics covered in previous editions.
Professor James Wolffsohn, IMI Chief Scientific Officer stated, “We have brought together the leading experts in myopia research from across the globe once again to ensure that clinicians have the latest information on myopia control to provide the best service to their patients, to highlight areas where more research is required and to guide the ophthalmic industry in the development of products needed for the future.”
Access the 2023 IMI White Papers at IOVS and at myopiainstitute.org/imi-white-papers.
The IMI 2019 and 2021 White Papers are available at IOVS (Series One, Series Two) and at myopiainstitute.org/imi-white-papers.
The IMI 2019 and 2021 clinical summaries, in many international languages, are available at myopiainstitute.org, with the 2023 IMI White Paper clinical summaries to be released soon.